Manufacturer record
USV Private Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by USV Private Limited (Himachal Pradesh) were declared Not of Standard Quality between August 2022 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 60002727, Metformin Hydrochloride Prolonged-Released and Glimepiride Tablets IP (exp Feb 2028). CDTL, Indore (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Manufacture's Specification with respect to the test for Dissolution of Metformin Hydrochloride. Listed in the July 2026 alert.
Records by type
5 records linked to USV Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metformin Hydrochloride Prolonged-Released and Glimepiride Tablets IP | Batch 60002727Mfg Mar 2026 · Exp Feb 2028 | The sample does not conform to claim as per Manufacture's Specification with respect to the test for Dissolution of Metformin Hydrochloride.Dissolution | CDTL, IndoreCDSCO lab | Jul 2026 |
| Glipizide and Metformin Tablets IP (Glynase-MF) | Batch 4010026Mfg Nov 2023 · Exp Apr 2025 | Dissolution of GlipizideDissolution | CDL KolkataCDSCO lab | Jun 2024 |
| GLIPIZIDEAND METFORMIN TABLETS IP | Batch 4010026Mfg Nov 2023 · Exp Apr 2025 | The sample does not conform to claim I.P. with respect to the test for Dissolution of GlipizideDissolution | CDL KolkataCDSCO lab | May 2024 |
| Fenofibrate Capsules IP 200 mg (LIPICARD) | Batch 28022587Mfg Nov 2021 · Exp Oct 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2023 |
| Methylcobalamin and Alpha Lipoic Acid Capsules | Batch 28021831Mfg Apr 2021 · Exp Feb 2023 | Description and Assay of Alpha Lipoic AcidAssay | RDTL GuwahatiCDSCO lab | Aug 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.